Jaguar Health Inc. (JAGX) and Fortress Biotech Inc. (NASDAQ:FBIOP) Comparing side by side

Since Jaguar Health Inc. (NASDAQ:JAGX) and Fortress Biotech Inc. (NASDAQ:FBIOP) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation of both companies.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jaguar Health Inc. 4.36M 1.63 40.69M -5.21 0.00
Fortress Biotech Inc. 228.27M 0.52 69.68M -1.59 0.00

In table 1 we can see Jaguar Health Inc. and Fortress Biotech Inc.’s gross revenue, earnings per share and valuation.

Profitability

Table 2 shows us Jaguar Health Inc. and Fortress Biotech Inc.’s net margins, return on assets and return on equity.

Net Margins Return on Equity Return on Assets
Jaguar Health Inc. -933.26% -260% -87.4%
Fortress Biotech Inc. -30.53% 0% 0%

Insider & Institutional Ownership

Roughly 13.6% of Jaguar Health Inc. shares are held by institutional investors while 0% of Fortress Biotech Inc. are owned by institutional investors. About 17.39% of Jaguar Health Inc.’s share are held by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Jaguar Health Inc. -27.15% -32.39% -50.32% -81.37% -82.69% -84.37%
Fortress Biotech Inc. -5.5% 3.75% -9.29% -24.55% 0% -27.03%

For the past year Jaguar Health Inc. was more bearish than Fortress Biotech Inc.

Summary

On 7 of the 10 factors Fortress Biotech Inc. beats Jaguar Health Inc.

Napo Pharmaceuticals, Inc., a human health company, focuses on developing and commercializing novel gastrointestinal prescription products from plants. Its products include Mytesi, an FDA approved product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Napo Pharmaceuticals, Inc. was formerly known as PS Pharmaceuticals, Inc. The company was founded in 2001 and is based in San Francisco, California.